Olga V. Zhukova

Olga V. Zhukova

Auto-generated profile, based on publicly available information

Olga V. Zhukova

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Problems of Nutrition
Verified
Journal Article
Closed access
ESEvgenia Shikh
Evgenia Shikh
VDV.N. Drozdov
V.N. Drozdov
OVO.A. Vorobieva
O.A. Vorobieva
OZO.V. Zhukova
O.V. Zhukova
AEA.S. Ermolaeva
A.S. Ermolaeva
ABAlina Bagdasaryan
Alina Bagdasaryan
Возможности применения пробиотика БИФИФОРМ КИДС с целью профилактики заболеваемости острыми респираторными вирусными инфекциями у детей

29 September 2022 in GYNECOLOGY
Verified
Journal Article
Open access
PDF file
ESEvgenia Shikh
Evgenia Shikh
LGLudmila Yu. Grebenshikova
Ludmila Yu. Grebenshikova
OZOlga V. Zhukova
Olga V. Zhukova
ABAlina Bagdasaryan
Alina Bagdasaryan
ШВШих Евгения Валерьевна
Ших Евгения Валерьевна
ГЮГребенщикова Людмила Юрьевна
Гребенщикова Людмила Юрьевна
About 187 million couples worldwide suffer from infertility, with the male factor being diagnosed in 2070% of cases. The main cause of idiopathic infertility has been recognized as the adverse effects of reactive oxygen species. On the one hand, the cellular antioxidant defense is a highly efficient multilevel system; therefore, the pharmacological targets may vary. On the other hand, antioxidant enzymes (superoxide dismutase, catalase, peroxidase) have high activity and specificity, which limits the pharmacological capabilities of direct antioxidants. Indirect methods, such as the normalization of mitochondrial function, are more promising. Mitochondria play a key role in providing energy for sperm motility (one of the main factors of male fertility). Myo-inositol (MI) derivatives involved in cell signaling regulate intracellular Ca2+ ion levels affecting mitochondrial oxidative metabolism and adenosine triphosphate production. Thus, mitochondrial antioxidants are of particular interest for therapeutic strategies. Currently, various routes and regimens of MI use in the treatment of males with oligo-astheno-teratozoospermia (OAT) are being considered in clinical practice. MI-based oral nutraceutical complexes for the treatment of male factor infertility contain both direct and indirect antioxidants. In vitro studies revealed damage to mitochondrial cristae in the sperm intermediate tract in patients with OAT. Experimental studies have demonstrated that mitochondrial structure is restored when sperm are incubated in an MI-containing medium. Clinical studies confirmed that sperm incubation in such an environment leads to increased sperm motility and viability in patients with OAT. Intravaginal administration of MI showed increased total sperm motility and an increased proportion of progressively motile sperm. It is the progressive motility that is considered the best marker for identifying quality and healthy sperm. This type of sperm is usually used for in vitro fertilization techniques. In addition, intravaginal MI administration improved the quality of cervical mucus and reduced its viscosity and crystallization. The effect of intravaginal MI on cervical mucus can be considered as an additional independent factor in increasing fertility.

10 January 2024 in Лечащий врач
Verified
Journal Article
Closed access
ESEvgenia Shikh
Evgenia Shikh
OZO.V. Zhukova
O.V. Zhukova
Background. Urinary tract infections are a pressing problem of modern medicine due to their widespread prevalence and socio-economic significance. Every year, recurrent urinary tract infections occur in more than 150 million people worldwide, which is second only to acute respiratory infections in incidence. In addition, the problem is not only medical, but also socio-economic in nature, since in most cases recurrent urinary tract infections occur among the working population. This can lead to temporary disability and a large number of outpatient consultations. Recurrent urinary tract infections are one of the main causes of hospital-acquired infections, which leads to serious financial expenses. In addition, the quality of life of such patients is significantly impaired: frequent relapses lead to disruption of the psycho-emotional state, the development of neuroses and psychosomatic pathology. Results. Currently, antibiotic therapy takes the leading position in the treatment of recurrent urinary tract infections, as clearly indicated by both national and European clinical guidelines. At the same time, it should be noted that the tactics of preventive measures remain not fully developed and require further study and the formation of an evidence base. Due to the development of antibiotic resistance, including due to the irrational use of antibacterial drugs, and frequent adverse reactions, the role of non-antibacterial drugs in maintaining the health of the urinary tract is increasingly discussed in the literature. According to clinical guidelines developed by the European Association of Urology, antimicrobial drugs for prevention of relapses is addressed only in cases where the use of non-antibacterial agents has proven ineffective. Currently, European recommendations for the prevention of recurrent urinary tract infections include non-antibacterial agents such as D-mannose; preparations containing cranberries and/or products of its processing. Russian recommendations indicate the significant role of herbal medicine in the prevention of relapses of cystitis in women. Despite the fact that many non-antibacterial agents are already included in recommendations for the prevention of recurrent urinary tract infections, both European and national, their mechanism of action, dosage regimen, and duration of administration continue to be actively studied. Conclusion. The currently accumulated clinical experience and research data indicate the great potential of such non-antibacterial agents as D-mannose, cranberry, vitamin D, birch leaf extract, which are part of the dietary supplement and can be used to maintain the health of the urinary tract.

13 August 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
ESEvgenia Shikh
Evgenia Shikh
NSN. N. Shindryaeva
N. N. Shindryaeva
RERebrova Ekaterina
Rebrova Ekaterina
NLN. I. Lapidus
N. I. Lapidus
OZO. V. Zhukova
O. V. Zhukova
IKI. G. Koroleva
I. G. Koroleva
Introduction. In recent years, data have been accumulated regarding possible associations between cognitive impairment and atrial fibrillation. The results of retrospective and prospective studies confirm that anticoagulant therapy in patients with AF can reduce the risk of cognitive impairment and dementia.Objective. To study the individual characteristics of elderly and senile patients with atrial fibrillation, influencing the choice of anticoagulant therapy, with a view to its subsequent optimization.Materials and methods. The study included 159 patients with atrial fibrillation of non-valvular genesis aged over 60 years. 4 groups of patients were formed. The largest number of patients received rivaroxaban and warfarin (36.4% and 34.6%, respectively). 26 (16.3%) patients were treated with dabigatran, 20 (12.6%) patients with apixaban. The risk of thromboembolic complications was assessed on the CHA2DS2-VASc scale. The HAS-BLED scale was used to assess the risk of bleeding. A pharmacogenetic study (carriage of polymorphic alleles of the CYP2C9 and VCORC1 genes) was conducted in 138 patients. Cognitive impairment was assessed by a Mini-Cog test and a battery of frontal tests.Results. Taking oral anticoagulants reduces the risk of stroke and dementia in patients; the presence of cognitive impairment, in turn, significantly reduces the patient’s adherence to therapy and reduces the effectiveness of therapy. Patients’ adherence to therapy was significantly lower by 10–20% in patients with cognitive impairment according to the Mini-Cog test and a battery of frontal tests. In the absence of pronounced cognitive impairment (higher adherence to treatment) and availability and willingness to control INR, warfarin remains the drug of choice in patients with renal insufficiency.Conclusions. A number of problems with the use of oral anticoagulants in elderly patients with atrial fibrillation have been identified. The ease of use of new oral anticoagulants, the absence of the need to select doses and monitor therapy is an important factor when choosing a drug.

1 January 2023 in Voprosy Ginekologii, Akušerstva i Perinatologii
Verified
Journal Article
Closed access
ESEvgenia Shikh
Evgenia Shikh
AMA.A. Makhova
A.A. Makhova
NSN.V. Shikh
N.V. Shikh
TMT.V. Marin
T.V. Marin
OZO.V. Zhukova
O.V. Zhukova
Phytoestrogens in combination with nutraceuticals are often used as a non-hormonal strategy for managing menopausal symptoms. The evidence base for the effectiveness of phytoestrogens remains controversial, which is due to the presence of several compounds of different chemical classes and levels of phytoestrogenic activity. The design of clinical trials (inadequate dosage, short observation period, small sample size, group heterogeneity) may be the reason for the result of insufficient efficacy. The effects of phytoestrogens on the reproductive system have been confirmed by preclinical studies. Phytoestrogens are considered as protectors of hormone-dependent proliferative processes and as agents for preventing cardiovascular diseases and reducing cardiometabolic risks in women with low estrogen levels. Data from a systematic review of compounds with high activity (genistein, daidzein, isoxanthohumol, biochanin A and B) have shown that phytoestrogens reduce hot flashes even with the placebo effect. The literature provides evidence for statistical and clinically significant efficacy of using a standardized red clover extract containing isoflavones to relieve menopausal symptoms. The effectiveness increases when it is synergistically combined with other micronutrients. Key words: phytoestrogens, red clover, flaxseed, menopause

22 November 2024 in Vestnik dermatologii i venerologii
Verified
Journal Article
Open access
PDF file
ESEvgenia Shikh
Evgenia Shikh
OZOlga V. Zhukova
Olga V. Zhukova
MKMaria S. Konstantinova
Maria S. Konstantinova
AKAnastasiia S. Koliadko
Anastasiia S. Koliadko
ШВШих Евгения Валерьевна
Ших Евгения Валерьевна
КСКолядко Анастасия Сергеевна
Колядко Анастасия Сергеевна
Background. Aging is a complex biological process of gradual metabolic, structural and functional changes in the body, which can lead to a decline in physical and mental functions, as well as to the development of diseases. At the moment, the issue of anti-aging remains relevant, given the steady increase in life expectancy and the growing proportion of the elderly population, which is observed practically worldwide. Biologically active supplements containing components used as part of complex therapy for the correction and prevention of signs of premature skin aging are becoming increasingly popular. Aims. To evaluate the effectiveness and safety of taking the dietary supplement VITABEAUTY® Hyaluronic Acid + Resveratrol on the functional parameters of facial skin. Methods. A simple blind placebo-controlled cross-over study was conducted, involving 40 female patients over 18 years old with signs of aging. The observation was carried out for 10 weeks. The dietary supplement and placebo were taken according to the following scheme: during the first 4 weeks of the study patients received placebo, then the subjects took VITABEAUTY® Hyaluronic Acid + Resveratrol for the next 6 weeks. Objective assessment of skin condition was carried out in 4 and 10 weeks after the beginning of the study in strictly fixed areas of the forehead and cheek. The patients’ subjective evaluation of the effectiveness of the supplement VITABEAUTY® Hyaluronic Acid + Resveratrol also was carried out. Results. Statistically significant improvement of skin moisture and wrinkle depth was registered at the end of the study at patiens receiving VITABEAUTY® Hyaluronic Acid + Resveratrol. 95% of the subjects evaluated the result of taking the dietary supplement as good and satisfactory. Conclusion. The obtained results allow us to recommend the dietary supplement VITABEAUTY® Hyaluronic Acid + Resveratrol for regular intake to prevent and/or control the initial signs of skin aging.